Chronic elevation of serum prolactin (PRL) level, hyperprolactinemia (hyperPRL) induced by prolactin-secreting adenoma or ectopic pituitary glands, results in suppression of gonadotropin secretion, increases in adrenal weights [3] and deficits in copulatory behavior in experimental animals [6 , 8 , 9 ,12] . It has been repeatedly demonstrated that chronic hyperPRL inhibits Copulatory behavior in male rats [6, 8, 12] . The effects of hyperPRL on male sexual activity include significant inhibition of both sexual arousal and erectile function [7] .
In human, hyperPRL is caused by or associated with, a variety of pathogenic states pituitary adenoma, hypothalamic disorders, hypogonadism and hypothyroidism, and is detected in patients with infertility [17, 18] , impotence and hypogonadism [19] .
Therapy for hyperPRL has been successful in many cases treated by either transsphenoidal surgery [14] or medical therapy with dopamine agonists, ergotic drugs, especially bromocriptine (CB-154) [19] . Dopamine agonists are very effective in decreasing serum PRL levels and in inducing tumor shrinkage of patients bearing PRL-secreting adenomas [4, 13] . CB-154 treatments have been reported to restore sexual function in hyperprolactinemic men [17, 18] and to increase copulatory behavior in hyperprolactinemic male rats [5] .
The present study was undertaken to confirm the suppressive effects of hyperPRL induced by grafting pituitary glands and clarify the effects of CB-154 treatment on male Copulatory behavior in hyperprolactinemic rats.
Wistar-Imamichi male rats obtained from Imamichi Institute for Animal Reproduction (Tsuchiura) were maintained on a 14-hr light and l0-hr dark lighting schedule (light off at 19:00). Animals were housed in a temperature- (P<0.05) in the animals with CB-154 treatment for 7 days was observed. Furthermore, the grafted animals with CB-154 treatment for 3 days showed significant decrease in both EL (P <0.01) and MF (P<0.01) in addition to a significant increase in both EF (P<0.01) and HR (P <0.01), compared with those in the grafted animal with vehicle.
The results of serum hormone and weights relative to body weight of each organ are shown in Tables 2 and 3 . It has been confirmed that there was no significant difference in the concentration of serum testosterone between treatment and control groups in the previous study [12] . The concentration of serum PRL in grafted animals was significantly higher than that in control animals. Serum level of PRL in the grafted animals with CB-154 treatments was significantly decreased when compared to grafted animals with vehicle (P<0.01) and sham operated controls (P<0.05) . Although hyperPRL has been reported to be associated with an increase in the adrenal weight and with the suppression of gonadotropin secretion [3] , there were no significant differences in the weight relative to body weight to adrenal glands and in the serum levels of gonadotropin between control and grafted groups.
The present study clearly demonstrated that the hyperPRL induced by pituitary grafts resulted in a significant suppression of copulatory behavior and the CB-154 treatment restored the suppressed copulatory behavior to its normal level. In the present experiment, CB -154 treatment to hyperprolactinemic rats for 3 days was more effective on copulatory behavior than treatment for 7 days. This result was inconsistent to the report by Doherty et al. [5] . The effects of CB-154 treatment for 7 days and 14 days on the grafted male CD-F rats were investigated in their studies in which a long term treatment of CB-154 was found to be more effective on copulatory behavior. It might be supposed that such a discrepancy was mainly due to the strain difference in sensitivity to CB-154. Besides, dopamine agonist tolerance may develop in the grafted animals with CB-154 for 7 days. The fact that in their studies the grafted animals showed a reduction in serum gonadotropin level may participate with such differences. Without altering serum concentrations of FSH and LH, the short term (3 days) treatment is effective enough to improve copulatory behavior in male rats with pituitary transplants.
These results may imply that PRL has direct actions on the central nervous system (CNS) and inhibits copulatory behavior in hyperploractinemic male rats. 
